{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:21:35Z","timestamp":1782516095548,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1475-2875-13-299","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T03:00:59Z","timestamp":1407207659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei"],"prefix":"10.1186","volume":"13","author":[{"given":"Joseph A","family":"Badejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyindamola O","family":"Abiodun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olugbenga","family":"Akinola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T","family":"Happi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akintunde","family":"Sowunmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace O","family":"Gbotosho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"3342_CR1","unstructured":"WHO briefing on malaria treatment guidelines and artemisinin mono therapy. 2006, Geneva: World Health Organization"},{"key":"3342_CR2","volume-title":"Guidelines for treatment of malaria","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Guidelines for treatment of malaria. 2010, http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241547925\/en\/ Accessed 8th June 2013"},{"key":"3342_CR3","volume-title":"World malaria report","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: World malaria report. 2011, http:\/\/www.who.int\/malaria\/world_malaria_report_2011\/en\/ Accessed 08th June 2013"},{"key":"3342_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1098\/rstb.1999.0426","volume":"354","author":"N White","year":"1999","unstructured":"White N: Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci. 1999, 354: 739-749. 10.1098\/rstb.1999.0426.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3342_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0035-9203(01)90254-8","volume":"95","author":"NM Huong","year":"2001","unstructured":"Huong NM, Hewitt S, Davis TME, Dao LD, Toan TQ, Kim TB, Hanh NT, Phuong VN, Nhan DH, Cong LD: Resistance of Plasmodium falciparum to antimalarial drugs in a highly endemic area of southern Viet Nam: a study in vivo and in vitro. Trans R Soc Trop Med Hyg. 2001, 95: 325-329. 10.1016\/S0035-9203(01)90254-8.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3342_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0035-9203(03)90127-1","volume":"97","author":"H Yang","year":"2003","unstructured":"Yang H, Liu D, Yang Y, Fan B, Yang P, Li X, Li C, Dong Y, Yang C: Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. Trans R Soc Trop Med Hyg. 2003, 97: 226-228. 10.1016\/S0035-9203(03)90127-1.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3342_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1056\/NEJMc0900231","volume":"361","author":"H Noedl","year":"2009","unstructured":"Noedl H, Socheat D, Satimai W: Artemisinin-resistant malaria in Asia. N Engl J Med. 2009, 361: 540-541. 10.1056\/NEJMc0900231.","journal-title":"N Engl J Med"},{"key":"3342_CR8","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1128\/AAC.01304-09","volume":"54","author":"P Lim","year":"2010","unstructured":"Lim P, Wongsrichanalai C, Chim P, Khim N, Kim S, Chy S, Sem R, Nhem S, Yi P, Duong S, Bouth DM, Genton B, Beck HP, Gobert JG, Rogers WO, Coppee J-Y, Fandeur T, Mercereau-Puijalon O, Ringwald P, Le Bras J, Ariey F: Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefl oquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Antimicrob Agents Chemother. 2010, 54: 2135-2142. 10.1128\/AAC.01304-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"3342_CR9","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(05)67787-2","volume":"366","author":"R Jambou","year":"2005","unstructured":"Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O: Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005, 366: 1960-1963. 10.1016\/S0140-6736(05)67787-2.","journal-title":"Lancet"},{"key":"3342_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056\/NEJMoa0808859.","journal-title":"N Engl J Med"},{"key":"3342_CR11","first-page":"238","volume":"74","author":"DF Clyde","year":"1971","unstructured":"Clyde DF, Miller RM, DuPont HL, Hornick RB: Antimalarial effects of tetracyclines in man. J Trop Med Hyg. 1971, 74: 238-242.","journal-title":"J Trop Med Hyg"},{"key":"3342_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4269\/ajtmh.1983.32.221","volume":"32","author":"TG Geary","year":"1983","unstructured":"Geary TG, Jensen JB: Effects of antibiotics on Plasmodium falciparum in vitro. Am J Trop Med Hyg. 1983, 32: 221-225.","journal-title":"Am J Trop Med Hyg"},{"key":"3342_CR13","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/AAC.00527-07","volume":"51","author":"EL Dahl","year":"2007","unstructured":"Dahl EL, Rosenthal PJ: Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob Agents Chemother. 2007, 51: 3485-3490. 10.1128\/AAC.00527-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"3342_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1128\/AAC.32.8.1182","volume":"32","author":"AA Divo","year":"1998","unstructured":"Divo AA, Sartorelli AC, Patton CL, Bia FJ: Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro. Antimicrob Agents Chemother. 1998, 32: 1182-1186.","journal-title":"Antimicrob Agents Chemother"},{"key":"3342_CR15","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1128\/AAC.47.8.2636-2639.2003","volume":"47","author":"N Mahmoudi","year":"2003","unstructured":"Mahmoudi N, Ciceron L, Franetich JF, Farhati K, Silvie O, Eling W, Sauerwein R, Danis M, Mazier D, Derouin F: In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp. Antimicrob Agents Chemother. 2003, 47: 2636-2639. 10.1128\/AAC.47.8.2636-2639.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"3342_CR16","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1086\/508175","volume":"43","author":"H Noedl","year":"2006","unstructured":"Noedl H, Krudsood S, Chalermratana K, Silachamroon U, Leowattana W, Tangpukdee N, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Sriwichai S, Rowan J, Bhattacharyya H, Ohrt C, Knirsch C: Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin Infect Dis. 2006, 43: 1264-1271. 10.1086\/508175.","journal-title":"Clin Infect Dis"},{"key":"3342_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1128\/AAC.01023-06","volume":"51","author":"H Noedl","year":"2007","unstructured":"Noedl H, Krudsood S, Leowattana W, Tangpukdee N, Thanachartwet W, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Yingyuen K, Ohrt C, Knirsch C: In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob Agents Chemother. 2007, 51: 651-656. 10.1128\/AAC.01023-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"3342_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4269\/ajtmh.2001.64.223","volume":"64","author":"WR Taylor","year":"2001","unstructured":"Taylor WR, Widjaja H, Richie TL, Basri H, Ohrt C, Tjitra E, Tanfik E, Jones TR, Kain KC, Hoffman SL: Chloroquine\/doxycycline combination versus chloroquine alone, and doxycycline alone for treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia. Am J Trop Med Hyg. 2001, 64: 223-228.","journal-title":"Am J Trop Med Hyg"},{"key":"3342_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00436-011-2573-3","volume":"110","author":"GO Gbotosho","year":"2012","unstructured":"Gbotosho GO, Happi CT, Woranola O, Abiodun OO, Sowunmi A, Oduola AM: Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei. Parasitol Res. 2012, 110: 895-899. 10.1007\/s00436-011-2573-3.","journal-title":"Parasitol Res"},{"key":"3342_CR20","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1128\/AAC.45.6.1746-1750.2001","volume":"45","author":"B Pradines","year":"2001","unstructured":"Pradines B, Rogier C, Fusai T, Mosnier J, Daries W, Barret E, Parzy D: In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrob Agents Chemother. 2001, 45: 1746-1750. 10.1128\/AAC.45.6.1746-1750.2001.","journal-title":"Antimicrob Agents Chemother"},{"key":"3342_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1128\/AAC.38.3.511","volume":"38","author":"S Pukrittayakamee","year":"1994","unstructured":"Pukrittayakamee S, Viravan C, Charoenlarp P, Yeamput C, Wilson RJ, White NJ: Antimalarial effect of rifampicin in Plasmodium vivax malaria. Antimicrob Agents Chemother. 1994, 38: 511-10.1128\/AAC.38.3.511.","journal-title":"Antimicrob Agents Chemother"},{"key":"3342_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0035-9203(93)90497-E","volume":"87","author":"M Strath","year":"1993","unstructured":"Strath M, Scott-Finnigan T, Gardner M, Williamson D, Wilson I: Antimalarial activity of rifampicin in vitro and in rodent models. Trans R Soc Trop Med Hyg. 1993, 87: 211-216. 10.1016\/0035-9203(93)90497-E.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3342_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000007167","volume":"45","author":"H Goerg","year":"1999","unstructured":"Goerg H, Ochola SA, Goerg R: Treatment of malaria tropica with a fixed combination of rifampicin, co-trimoxazole and isoniazid: a clinical study. Chemotherapy. 1999, 45: 68-76. 10.1159\/000007167.","journal-title":"Chemotherapy"},{"key":"3342_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/jac\/dkn330","volume":"62","author":"M Sousa","year":"2008","unstructured":"Sousa M, Pozniak A, Boffito M: Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs. J Antimicrob Chemother. 2008, 62: 872-878. 10.1093\/jac\/dkn330.","journal-title":"J Antimicrob Chemother"},{"key":"3342_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/00003088-200140050-00003","volume":"40","author":"PT Giao","year":"2001","unstructured":"Giao PT, de Vries PJ: Pharmacokinetic interactions of antimalarial agents. Clin Pharmacokinet. 2001, 40: 343-373. 10.2165\/00003088-200140050-00003.","journal-title":"Clin Pharmacokinet"},{"key":"3342_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/00003088-200847020-00002","volume":"47","author":"FT Aweeka","year":"2008","unstructured":"Aweeka FT, German PI: Clinical pharmacology of artemisinin-based combination therapies. Clin Pharmacokinet. 2008, 47: 91-102. 10.2165\/00003088-200847020-00002.","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 1","key":"3342_CR27","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1476-5381.2011.01649_1.x","volume":"164","author":"SPH Alexander","year":"2011","unstructured":"Alexander SPH, Mathie A, Peters JA: Guide to receptors and channels (GRAC). Br J Pharmacol. 2011, 164 (Suppl. 1): S1-S324.","journal-title":"Br J Pharmacol"},{"key":"3342_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1476-5381.2012.02033.x","volume":"167","author":"O Burk","year":"2012","unstructured":"Burk O, Piedade O, Ghebreghioghis L, Fait JT, Nussler AK, Gil JP, Windshuge B, Schwab M: Differential effects of clinically used derivatives and metabolites of artemisinin in the activation of constitutive androstane receptor isoforms. Br J Pharmacol. 2012, 167: 666-681.","journal-title":"Br J Pharmacol"},{"key":"3342_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0014-4894(65)90012-3","volume":"17","author":"W Peters","year":"1965","unstructured":"Peters W: Drug resistance in Plasmodium berghei. I Chloroquine Resist Exp Parasitol. 1965, 17: 80-89.","journal-title":"I Chloroquine Resist Exp Parasitol"},{"key":"3342_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/227381b0","volume":"227","author":"NE Alger","year":"1970","unstructured":"Alger NE, Spira DT, Silverman PH: Inhibition of rodent malaria in mice by rifampicin. Nature. 1970, 227: 381-382.","journal-title":"Nature"},{"key":"3342_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1128\/AAC.13.6.1011","volume":"13","author":"LH Schmidt","year":"1978","unstructured":"Schmidt LH, Crosby R, Rasco J, Vaughan D: Antimalarial activities of various 4- quinoline methanols with special attention to WR- 142,490 (mefloquine). Antimicrob Agents Chemother. 1978, 13: 1011-1030. 10.1128\/AAC.13.6.1011.","journal-title":"Antimicrob Agents Chemother"},{"key":"3342_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1289\/ehp.94102s9101","volume":"102","author":"M Strolin Benedetti","year":"1994","unstructured":"Strolin Benedetti M, Dostert P: Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies. Environ Health Perspect. 1994, 102: 101-105. 10.1289\/ehp.94102s4101.","journal-title":"Environ Health Perspect"},{"key":"3342_CR33","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1097\/QAD.0b013e32835cae3b","volume":"27","author":"M Lamorde","year":"2013","unstructured":"Lamorde M, Byakika-Kibwika P, Mayito J, Nabukeera L, Ryan M, Hanpithakpong W, Lef\u00e8vre G, Back DJ, Khoo SH, Merry C: Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment. AIDS. 2013, 27: 961-965. 10.1097\/QAD.0b013e32835cae3b.","journal-title":"AIDS"},{"key":"3342_CR34","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1128\/AAC.47.11.3458-3463.2003","volume":"47","author":"S Pukrittayakamee","year":"2003","unstructured":"Pukrittayakamee S, Wanwimolruk S, Stepniewska K, Jantra A, Huyakorn S, Looareesuwan S, White NJ: Quinine pharmacokinetics - pharmacodynamics relationships in uncomplicated falciparum malaria. Antimicrob Agents Chemother. 2003, 47: 3458-3463. 10.1128\/AAC.47.11.3458-3463.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"3342_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1600-0773.1999.tb02019.x","volume":"85","author":"P Damkier","year":"1999","unstructured":"Damkier P, Hansen LL, Bresen K: Rifampicin treatment greatly increases the apparent oral clearance of quinidine. Pharmacol Toxicol. 1999, 85: 257-262.","journal-title":"Pharmacol Toxicol"},{"key":"3342_CR36","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1211\/0022357001777243","volume":"52","author":"W Ridtitid","year":"2000","unstructured":"Ridtitid W, Wongnawa M, Mahatthanatrakul W, Chaipol P, Sunbhanich M: Effect of rifampin on plasma concentrations of mefloquine in healthy volunteers. J Pharm Pharmacol. 2000, 52: 1265-1269. 10.1211\/0022357001777243.","journal-title":"J Pharm Pharmacol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-13-299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:16:53Z","timestamp":1630559813000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-13-299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3342"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-13-299","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]},"assertion":[{"value":"25 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"299"}}